Abstract
We compared electronic medication monitoring and electronic monitoring adjusted by interview with an unannounced pill-count adherence measure, in a cross-sectional analysis (n = 42). We used the following measures (a) electronic monitored doses (EMD: # medication monitor openings/# doses prescribed), (b) adjusted electronically monitored doses (AEMD: EMD adjusted by the number of extra openings and extra doses removed), (c) percentage of days dose taken (PDDT: % days the medication monitor was opened at least once, and (d) unannounced pill count (PC). The results showed that AEMD, EMD, and PDDT were significantly associated with PC adherence. AEMD explained 83% of the variation in PC adherence, EMD 49%, and PDDT 58%. EMD adherence was significantly lower than PC adherence (p = .02). Electronic medication monitoring measures were closely related to PC adherence. AEMD was more closely associated than EMD or PDDT. EMD may underestimate adherence due to the removal of multiple doses from the bottle at one time.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Arnet, I., and Haefeli, W. E. (2000). Overconsumption detected by electronic drug monitoring requires subtle interpretation. Clinical Pharmacology and Therapeutics, 67, 44–47.
Bangsberg, D. R., Hecht, F. M., Charlebois, E. D., Zolop, A. R., Holodniy, M., Sheiner, L., Bamberger, J. D., Chesney, M. A., and Moss, A. (2000). Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population, AIDS, 14, 357–366.
Bangsberg, D., and Moss, A. (1999).When should we delay highly active antiretroviral therapy? Journal of General Internal Medicine, 14, 446–448.
Bangsberg, D., Tulsky, J. P., Hecht, F. M., and Moss, A. R. (1997). Protease inhibitors in the homeless. JAMA, 278, 63–65.
Craig, H. M. (1985). Accuracy of indirect measures of medication compliance in hypertension, Research in Nursing Health, 8, 61–66.
Descampes, D., Flandre, P., Calvez, V., Petavin, G., Meiffredy, V., Collin, G., Delaugerre, C., Robert-Delmas, S., Bazin, B., Aboulker, J., Pialoux, G., Raffi, F. and Brun-Vezinet, F. (2000). Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy, JAMA, 283, 205–211.
Farmer, K. C. (1999). Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice, Clinical Therapeutics, 21, 1074–1090; discussion 1073.
Gerbert, B., Abercombie, P., Bronstone, A., Clannon, K., and Bangsberg, D. (2000). Challenges in adherence:The providers' perspective, AIDS Care, 12, 409–421.
Gifford, A. L., Bormann, J. E., Shively, M. J., Wright, B. C., Richman, D. D., and Bozzette, S. A. (2000). Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens, Journal of Acquired Immune Deficiency Syndrome, 23, 386–395.
Gilbert, J. R., Evans, C. E., Haynes, R. B., and Tugwell, P. (1980). Predicting compliance with a regimen of digoxin therapy in family practice, Canadian Medical Association Journal, 123, 119–122.
Gordis, L., Markowitz, M., and Lilienfeld, A. M. (1969). Studies in the epidemiology and preventability of rheumatic fever. IV. Aquantitative determination of compliance in children on oral penicillin prophylaxis, Pediatrics, 43, 173–182.
Grymonpre, R. E., Didur, C. D., Montgomery, P. R., and Sitar, D. S. (1998). Pill count, self-report, and pharmacy claims data to measure medication adherence in the elderly, Annals of Pharmacotherapy, 32, 749–754.
Haubrich, R. H., Little, S. J., Currier, J. S., Forthal, D. N., Kemper, C. A., Beall, G. N., Johnson, D., Dube, M. P., Hwang, J. Y., and McCutchan, J. A. (1999). The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group, AIDS, 13, 1099–1107.
Havlir, D. V., Hellmann, N. S., Petropoulos, C. J., Whitcomb, J. M., Collier, A. C., Hirsch, M. S., Tebas, P., Sommadossi, J. P., and Richman, D. D. (2000). Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens [see comments], JAMA, 283, 229–234.
Inui, T. S., Carter, W. B., and Pecoraro, R. E. (1981). Screening for noncompliance among patients with hypertension: Is self-report the best availablemeasure? Medical Care, 19, 1061–1064.
Kastrissios, H., Suarez, J. R., Katzenstein, D., Girard, P., Sheiner, L. B., and Blaschke, T. F. (1998). Characterizing patterns of drug-taking behavior with a multiple drug regimen in an AIDS clinical trial, AIDS, 12, 2295–2303.
Lee, J. Y., Kusek, J. W., Greene, P. G., Bernhard, S., Norris, K., Smith, D., Wilkening, B., and Wright, J. T., Jr. (1996). Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study, American Journal of Hypertension, 9, 719–725.
Matsui,D., Hermann, C., Klein, J., Berkovitch, M., Olivieri, N., and Koren, G. (1994). Critical comparison of novel and existing methods of compliance assessment during a clinical trial of an oral iron chelator, Journal of Clinical Pharmacology, 34, 944–949.
Metry, J. M., and Meyer, U. A. (1999). Drug regimen compliance. Chichester, West Sussex: Wiley.
Paes, A. H., Bakker, A., and Soe-Agnie, C. J. (1998). Measurement of patient compliance, Pharmology World Science, 20, 73–77.
Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., Wagener, M. M., and Singh, N. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection, Annals of Internal Medicine, 133, 21–30.
Straka, R. J., Fish, J. T., Benson, S. R., and Suh, J. T. (1997). Patient self-reporting of compliance does not correspond with electronic monitoring: An evaluation using isosorbide dinitrate as a model drug, Pharmacotherapy, 17, 126–132.
Vanhove, G. F., Schapiro, J. M., Winters, M. A., Merigan, T. C., and Blaschke, T. F. (1996). Patient compliance and drug failure in protease inhibitor monotherapy [letter], JAMA, 276, 1955–1956.
Waterhouse, D. M., Calzone, K. A., Mele, C., and Brenner, D. E. (1993). Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring [see comments], Journal of Clinical Oncology, 11(6), 1189–1197.
Zolopa, A. R., Hahn, J. A., Gorter, R., Miranda, J., Wlodarczyk, D., Peterson, J., Pilote, L., and Moss, A. R. (1994). HIV and tuberculosis infection in San Francisco's homeless adults. Prevalence and risk factors in a representative sample [see comments], JAMA, 272(6), 455–461.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bangsberg, D.R., Hecht, F.M., Charlebois, E.D. et al. Comparing Objective Measures of Adherence to HIV Antiretroviral Therapy: Electronic Medication Monitors and Unannounced Pill Counts. AIDS Behav 5, 275–281 (2001). https://doi.org/10.1023/A:1011396711486
Issue Date:
DOI: https://doi.org/10.1023/A:1011396711486